Biohaven - Grave's Disease

  • Study Sponsor and Protocol Number: 
    Biohaven BHV-1300
  • Specialty:
    Primary Care
    Endocrinology
  • Type:
    Investigational Drug
  • Inclusion:
    Age 18 - 70
    Not currently receiving treatment for Grave's Disease
  • Exclusion:
    Other types of hyperthyroidism
    Thyroid storm
    Thyroid eye disease

    •